Diazepam Binding Inhibitor antibody
Quick Overview for Diazepam Binding Inhibitor antibody (ABIN631130)
Target
See all Diazepam Binding Inhibitor (DBI) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purification
- Affinity purified
-
Immunogen
- DBI antibody was raised using a synthetic peptide corresponding to a region with amino acids MSQAEFEKAAEEVRHLKTKPSDEEMLFIYGHYKQATVGDINTERPGMLDF
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
DBI Blocking Peptide, (ABIN5613127), is also available for use as a blocking control in assays to test for specificity of this DBI antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of DBI antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- Diazepam Binding Inhibitor (DBI)
-
Alternative Name
- DBI
-
Background
- DBI is diazepam binding inhibitor. The protein that is regulated by hormones and is involved in lipid metabolism and the displacement of beta-carbolines and benzodiazepines, which modulate signal transduction at type A gamma-aminobutyric acid receptors located in brain synapses. DBI is conserved from yeast to mammals, with the most highly conserved domain consisting of seven contiguous residues that constitute the hydrophobic binding site for medium- and long-chain acyl-Coenzyme A esters. Diazepam binding inhibitor is also known to mediate the feedback regulation of pancreatic secretion and the postprandial release of cholecystokinin, in addition to its role as a mediator in corticotropin-dependent adrenal steroidogenesis.
-
Molecular Weight
- 10 kDa (MW of target protein)
Target
-